Borkenstein Andreas F, Borkenstein Eva-Maria
Borkenstein & Borkenstein, Private Practice Privatklinik der Kreuzschwestern Graz Graz Austria.
Clin Case Rep. 2018 Nov 13;7(1):74-78. doi: 10.1002/ccr3.1912. eCollection 2019 Jan.
A new treatment option for cataracts and advanced ARMD: the simultaneous intravitreal injection of anti-vascular endothelial growth factor and implantation of a high-add IOL. We believe major opportunities arise from a new subcategory in cataract surgery-called magnifying surgery (MAGS). Our case proves the potential of this brand-new technology.
玻璃体内同时注射抗血管内皮生长因子并植入高附加值人工晶状体。我们认为,白内障手术中的一个新子类——放大手术(MAGS)带来了重大机遇。我们的病例证明了这项全新技术的潜力。